JUST RELEASED Paying for Cures Toolkit updated with new pipeline modeling and financing strategies Today FoCUS released an updated and expanded version of its Paying for Cures Toolkit, which is designed … Read More
LEAPS Monthly Recap: January 2022
RECENT PUBLICATION LEAPS research in Precision Reimbursement published in Clinical Pharmacology & Therapeutics The article, “Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-Predict,” appeared … Read More
Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues
Drug Discovery Today (2021). DOI: 10.1016/j.drudis.2021.09.001C. Young; C. Quinn; M. Trusheim. Durable cell and gene therapies potentially transform patient lives, but payers fear unsustainable costs arising from the more than … Read More
FoCUS Monthly Recap: December 2021
COMING SOON Paying for Cures Toolkit update in early ’22 After the holiday FoCUS will release a major update to the toolkit, including updates to the Pipeline and Individual Indication worksheets … Read More
LEAPS Monthly Recap: December 2021
DESIGN LAB REPORT LEAPS Design Lab advances pilot projects At the November 30 and December 1 Design Lab participants shaped the designs for three pilots to launch in 2022. … Read More
LEAPS Monthly Recap: October 2021
NEW MEMBER Flatiron Health joins LEAPS Project This month, Flatiron Health, the clinical and science data healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today … Read More
FoCUS Monthly Recap: October 2021
NEW SOLUTIONS Financing solutions emerging from the market: A FoCUS survey and analysis How are market leaders responding to the barriers of cost and uncertainty associated with cell and gene therapies … Read More
The NEWDIGS Initiative at MIT welcomes Flatiron Health as a new collaborator for the LEAPS Project
CAMBRIDGE, MA October 29, 2021 – Flatiron Health®, a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments, has joined the Massachusetts Institute … Read More
Precision for Whom? Partnering with patients to ensure that Precision Medicine targets what matters
Despite decades of growth and adaptation in patient engagement, knowing or being able to find guidance for whichmodel or approach will be most impactful in which healthcare or research context … Read More
FoCUS Monthly Recap: September 2021
NEW RESOURCES Self-Insured Employers Workshop shares practical advice for covering cell and gene therapies In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and … Read More